Le Bastard, Quentin
Jenvrin, Joel
Gaultier, Aurélie
Montassier, Emmanuel https://orcid.org/0000-0002-2313-1172
Funding for this research was provided by:
Ministère de l'Enseignement Supérieur et de la Recherche (PHRCN PHRC-21-0106)
Article History
Received: 11 June 2025
Accepted: 7 August 2025
First Online: 1 September 2025
Declarations
:
: The study protocol and all associated documents have been reviewed and approved by the relevant ethics committee (CPP Sud-Est II, approval date: November 8, 2023). Since the patient’s condition will not allow for consent to be sought, an emergency inclusion procedure will be applied (article L1122-1–2 of the French Public Health Code), and the continuation-of-care consent for the study will be signed by the patient as soon as possible. The informed consent process will be handled by authorized study personnel who are thoroughly familiar with the study and trained in ethical and legal aspects of obtaining consent, including the principal investigator (PI) and co-investigators, evaluator clinicians (physical therapists), and the study coordinator.
: See Appendix B.
: The authors declare that they have no competing interests.